BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23574786)

  • 21. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
    Sun ZG; Wang Z; Zhang M
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma.
    Xu S; Kitayama J; Yamashita H; Souma D; Nagawa H
    J Surg Oncol; 2008 Jan; 97(1):44-50. PubMed ID: 18000820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
    Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
    Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.
    Yuen HF; Chan YP; Law S; Srivastava G; El-Tanani M; Mak TW; Chan KW
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3593-602. PubMed ID: 19064576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway.
    Huang HM; He XH; Huang XY; Wang GY; Xia QX; Du ZP; Zhang YF
    Cell Commun Signal; 2022 Mar; 20(1):35. PubMed ID: 35305679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma.
    Baba Y; Watanabe M; Shigaki H; Iwagami S; Ishimoto T; Iwatsuki M; Baba H
    Surgery; 2013 Feb; 153(2):234-41. PubMed ID: 22980434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
    Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
    J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.
    Cui X; Li S; Li T; Pang X; Zhang S; Jin J; Hu J; Liu C; Yang L; Peng H; Jiang J; Liang W; Suo J; Li F; Chen Y
    Int J Clin Exp Pathol; 2014; 7(5):2382-91. PubMed ID: 24966948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma.
    Shiozaki A; Nakashima S; Ichikawa D; Fujiwara H; Konishi H; Komatsu S; Kubota T; Okamoto K; Iitaka D; Shimizu H; Nako Y; Takemoto K; Kishimoto M; Otsuji E
    Anticancer Res; 2013 Oct; 33(10):4329-35. PubMed ID: 24123000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
    Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
    J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
    Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
    Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.